L-Lysine HCl — living evidence map

Summary

Lysine is an essential amino acid with a well-established parenteral safety record, reviewed as a multifunctional excipient that suppresses aggregation, lowers viscosity in concentrated antibody formulations and protects during freeze-drying. · pmid:42462918

Identity

PubChem CID 69568: L-Lysine monohydrochloride, C6H15ClN2O2, 182.65 g/mol. · pubchem:69568

CAS registry number 657-27-2. · pubchem:69568

IUPAC name: (2S)-2,6-diaminohexanoic acid;hydrochloride. · pubchem:69568

Where the evidence actually sits

Proportion of the 1 claim about L-Lysine HCl standing at each tier. Community volume is shown on the Consensus tab beside this and is never averaged into it.

Living evidence history

1 resolved citation, oldest to newest, coloured by tier. Retractions and contradictions land here as they are recorded.

Structure

No structure representation on record. PepJunkie draws only what an authoritative record supplies; for a peptide that is the residue sequence, and none has been curated for L-Lysine HCl yet.

Dose evidence, rung by rung

A studied human dose exists on file. Open the rung: the dose is the paper's, in its context, never PepJunkie's.

1. Approved-label dose · a resolved regulatory document names a labelled dose

   nothing resolved on this rung

2. Studied human doses · resolved human studies at the established tier
   • Lysine as a multifunctional excipient for protein-based biopharmaceutical formulations. · pmid 42462918 · 2026
3. Observational evidence · resolved human data at the emerging tier: thin, or contested

   nothing resolved on this rung

4. Community-reported protocols · protocol propositions from distinct members, counted once per human

   nothing resolved on this rung

5. Preclinical evidence · resolved animal, cell or mechanistic work

   nothing resolved on this rung

1 resolved citation, 0 unresolved (an unresolved citation lends nothing). Community volume is its own rung and is never averaged into the evidence rungs.